Ignite Creation Date:
2025-12-25 @ 1:33 AM
Ignite Modification Date:
2026-02-25 @ 6:33 PM
Study NCT ID:
NCT03234894
Status:
UNKNOWN
Last Update Posted:
2020-01-30
First Post:
2016-06-28
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Clinical Trial of the WC360 SiteSeal Adjunctive Compression Device Following Interventional Endovascular Procedures
Sponsor:
Wound Care 360, Inc.
Organization:
Study Overview
Official Title:
Clinical Study of the WoundCare360 SiteSeal Adjunctive Compression Device Following Interventional Endovascular Procedures
Status:
UNKNOWN
Status Verified Date:
2020-01
Last Known Status:
ENROLLING_BY_INVITATION
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
SiteSeal
Brief Summary:
This Clinical Study is a pivotal study to evaluate the safety of the SiteSeal™ Adjunctive Compression Device across a broad array of patients undergoing interventional endovascular procedures.
Detailed Description:
The study design is a single arm with 90 patients. The primary endpoints measure the risk for common femoral nerve damage and common femoral artery laceration from the blind placement of a Z-stitch in the soft tissue above the femoral bundle.
The sample size is 90 patients. The project objective is to demonstrate the safety of the device.
The sample size is 90 patients. The project objective is to demonstrate the safety of the device.
Study Oversight
Has Oversight DMC:
True
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
True
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: